Valproic acid causes proteasomal degradation of DICER and influences miRNA expression

31Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

Valproic acid (VPA) is a commonly used drug to treat epilepsy and bipolar disorders. Known properties of VPA are inhibitions of histone deacetylases and activation of extracellular signal regulated kinases (ERK), which cannot fully explain VPA's clinical features. We found that VPA induces the proteasomal degradation of DICER, a key protein in the generation of micro RNAs. Unexpectedly, the concentration of several micro RNAs increases after VPA treatment, which is caused by the upregulation of their hosting genes prior to DICER degradation. The data suggest that a loss of DICER protein and changes in micro RNA concentration contributes to the clinical properties of VPA. VPA can be used experimentally to down regulate DICER protein levels, which likely reflects a natural regulation of DICER. © 2013 Zhang et al.

Cite

CITATION STYLE

APA

Zhang, Z., Convertini, P., Shen, M., Xu, X., Lemoine, F., De La Grange, P., … Stamm, S. (2013). Valproic acid causes proteasomal degradation of DICER and influences miRNA expression. PLoS ONE, 8(12). https://doi.org/10.1371/journal.pone.0082895

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free